SUPRATENTORIAL GLIOBLASTOMA
Clinical trials for SUPRATENTORIAL GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new SUPRATENTORIAL GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for SUPRATENTORIAL GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Brain cancer gene therapy trial pulled before it began
Disease control TerminatedThis study aimed to test whether adding a special virus (Toca 511) and a fungus-fighting drug (Toca FC) to standard chemotherapy and radiation could help people with newly diagnosed glioblastoma, an aggressive brain cancer. The virus was designed to make cancer cells convert the …
Matched conditions: SUPRATENTORIAL GLIOBLASTOMA
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 07:59 UTC
-
Immunotherapy combo shows promise against deadly brain cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation can help people with newly diagnosed glioblastoma, an aggressive brain cancer. About 52 adults will receive the combination to see if it improves survival and controls the …
Matched conditions: SUPRATENTORIAL GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 13:55 UTC